Fig. 5From: The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in GermanySubstitutive Study design with multiplicative and additive premium. Multiplicative and additive premiums or discounts are presented for cases with a substitutive study designBack to article page